Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond

Mike Sathekge, Alicia McFarren, Ekaterina Dadachova

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

HIV-associated neurocognitive disorders (HAND) remain among the most common clinical disorders encountered in people infected with HIV despite widespread use of antiretroviral therapy. There is an enormous need for further evaluation and early diagnosis of HAND. The variety of PET agents such as FDG, 11C-PiB and [11C]-R-PK11195 as well as SPECT agents 99Tc-HMPAO, 123I-FP-CIT and 123I-IBZM have been investigated for the diagnosis of HAND, for distinguishing between demented and nondemented HIV patients, for differentiation between HAND and nonHIV related dementia, as well as for assessing the influence of coinfection with the other viral pathogens on the brain functionality. In spite of some interesting results, none of these tracers have been specifically created for HAND and none can be recommended for HAND diagnosis. Specialized tracers need to be developed for better diagnosis and management of HAND. The potential role of therapeutic nuclear medicine as part of the curative strategies for HIV is also discussed.

Original languageEnglish (US)
Pages (from-to)792-796
Number of pages5
JournalNuclear Medicine Communications
Volume35
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Nuclear Medicine
Single-Photon Emission-Computed Tomography
HIV
Neurocognitive Disorders
Coinfection
Dementia
Early Diagnosis

Keywords

  • neuroHIV
  • PET
  • radioimmunotherapy
  • SPECT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Role of nuclear medicine in neuroHIV : PET, SPECT, and beyond. / Sathekge, Mike; McFarren, Alicia; Dadachova, Ekaterina.

In: Nuclear Medicine Communications, Vol. 35, No. 8, 2014, p. 792-796.

Research output: Contribution to journalArticle

Sathekge, Mike ; McFarren, Alicia ; Dadachova, Ekaterina. / Role of nuclear medicine in neuroHIV : PET, SPECT, and beyond. In: Nuclear Medicine Communications. 2014 ; Vol. 35, No. 8. pp. 792-796.
@article{ad641588e47843a9aadda04c84428764,
title = "Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond",
abstract = "HIV-associated neurocognitive disorders (HAND) remain among the most common clinical disorders encountered in people infected with HIV despite widespread use of antiretroviral therapy. There is an enormous need for further evaluation and early diagnosis of HAND. The variety of PET agents such as FDG, 11C-PiB and [11C]-R-PK11195 as well as SPECT agents 99Tc-HMPAO, 123I-FP-CIT and 123I-IBZM have been investigated for the diagnosis of HAND, for distinguishing between demented and nondemented HIV patients, for differentiation between HAND and nonHIV related dementia, as well as for assessing the influence of coinfection with the other viral pathogens on the brain functionality. In spite of some interesting results, none of these tracers have been specifically created for HAND and none can be recommended for HAND diagnosis. Specialized tracers need to be developed for better diagnosis and management of HAND. The potential role of therapeutic nuclear medicine as part of the curative strategies for HIV is also discussed.",
keywords = "neuroHIV, PET, radioimmunotherapy, SPECT",
author = "Mike Sathekge and Alicia McFarren and Ekaterina Dadachova",
year = "2014",
doi = "10.1097/MNM.0000000000000139",
language = "English (US)",
volume = "35",
pages = "792--796",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Role of nuclear medicine in neuroHIV

T2 - PET, SPECT, and beyond

AU - Sathekge, Mike

AU - McFarren, Alicia

AU - Dadachova, Ekaterina

PY - 2014

Y1 - 2014

N2 - HIV-associated neurocognitive disorders (HAND) remain among the most common clinical disorders encountered in people infected with HIV despite widespread use of antiretroviral therapy. There is an enormous need for further evaluation and early diagnosis of HAND. The variety of PET agents such as FDG, 11C-PiB and [11C]-R-PK11195 as well as SPECT agents 99Tc-HMPAO, 123I-FP-CIT and 123I-IBZM have been investigated for the diagnosis of HAND, for distinguishing between demented and nondemented HIV patients, for differentiation between HAND and nonHIV related dementia, as well as for assessing the influence of coinfection with the other viral pathogens on the brain functionality. In spite of some interesting results, none of these tracers have been specifically created for HAND and none can be recommended for HAND diagnosis. Specialized tracers need to be developed for better diagnosis and management of HAND. The potential role of therapeutic nuclear medicine as part of the curative strategies for HIV is also discussed.

AB - HIV-associated neurocognitive disorders (HAND) remain among the most common clinical disorders encountered in people infected with HIV despite widespread use of antiretroviral therapy. There is an enormous need for further evaluation and early diagnosis of HAND. The variety of PET agents such as FDG, 11C-PiB and [11C]-R-PK11195 as well as SPECT agents 99Tc-HMPAO, 123I-FP-CIT and 123I-IBZM have been investigated for the diagnosis of HAND, for distinguishing between demented and nondemented HIV patients, for differentiation between HAND and nonHIV related dementia, as well as for assessing the influence of coinfection with the other viral pathogens on the brain functionality. In spite of some interesting results, none of these tracers have been specifically created for HAND and none can be recommended for HAND diagnosis. Specialized tracers need to be developed for better diagnosis and management of HAND. The potential role of therapeutic nuclear medicine as part of the curative strategies for HIV is also discussed.

KW - neuroHIV

KW - PET

KW - radioimmunotherapy

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=84903788127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903788127&partnerID=8YFLogxK

U2 - 10.1097/MNM.0000000000000139

DO - 10.1097/MNM.0000000000000139

M3 - Article

C2 - 24781008

AN - SCOPUS:84903788127

VL - 35

SP - 792

EP - 796

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 8

ER -